Division of Maternal-Fetal Medicine, Massachusetts General Hospital, Boston, Massachusetts; and the Division of Maternal-Fetal Medicine, Weill Cornell Medicine, New York, New York.
Obstet Gynecol. 2023 Mar 1;141(3):473-482. doi: 10.1097/AOG.0000000000005100. Epub 2023 Jan 16.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pregnancy is associated with significant maternal morbidity and mortality, and its risks can be mitigated with coronavirus disease 2019 (COVID-19) vaccination. Vaccination against COVID-19 in pregnancy results in protection against both maternal and neonatal SARS-CoV-2 infection, as well as maternal critical illness. Vaccination during pregnancy is safe, with no documented risks of pregnancy loss, preterm delivery, congenital anomalies, or other adverse perinatal outcomes. For these reasons, COVID-19 vaccination is recommended in pregnancy by the Centers for Disease Control and Prevention, the American College of Obstetricians and Gynecologists, and the Society for Maternal-Fetal Medicine, as well as other national and international professional organizations. In this review, we will summarize the published literature demonstrating the benefit and safety of these vaccines.
严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染与妊娠相关的母体发病率和死亡率显著相关,其风险可以通过 2019 年冠状病毒病(COVID-19)疫苗接种来减轻。COVID-19 疫苗接种在妊娠期间可预防母体和新生儿 SARS-CoV-2 感染,以及母体重症疾病。妊娠期间接种疫苗是安全的,没有记录到流产、早产、先天畸形或其他不良围产期结局的风险。出于这些原因,疾病控制与预防中心、美国妇产科医师学会和母胎医学学会以及其他国家和国际专业组织都建议在妊娠期间接种 COVID-19 疫苗。在这篇综述中,我们将总结已发表的文献,证明这些疫苗的益处和安全性。